Aspiriant LLC’s GE Vernova GEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
1,083
+271
+33% +$277K 0.03% 156
2026
Q1
$709K Sell
812
-141
-15% -$110K 0.02% 187
2025
Q4
$623K Buy
953
+148
+18% +$90.1K 0.02% 199
2025
Q3
$495K Sell
805
-182
-18% -$110K 0.02% 200
2025
Q2
$522K Sell
987
-87
-8% -$36.2K 0.02% 190
2025
Q1
$328K Sell
1,074
-207
-16% -$72.2K 0.01% 227
2024
Q4
$421K Sell
1,281
-81
-6% -$25.3K 0.02% 205
2024
Q3
$347K Buy
+1,362
New +$262K 0.01% 219

Other funds holding GEV

Aspiriant LLC's GEV Position: Q2 2026 in Review

Aspiriant LLC increased its GE Vernova (GEV) stake by 33% in Q2 2026, buying an estimated $277K and bringing the position to 1,083 shares worth $1.27M. The position accounts for 0.03% of the portfolio, ranked #156.

Aspiriant LLC first reported a position in GEV in Q3 2024 and has held it in 8 quarters since. 3,444 funds tracked by Wall St. Rank hold GEV as of Q2 2026.

  • Aspiriant LLC held 1,083 shares of GE Vernova worth $1.27M as of Q2 2026.
  • Aspiriant LLC bought 271 GE Vernova shares in Q2 2026, an estimated $277K.
  • GE Vernova made up 0.03% of Aspiriant LLC's portfolio in Q2 2026, its #156 holding.
  • Aspiriant LLC first reported a position in GE Vernova in Q3 2024 and has held it in 8 quarters since.
  • 3,444 funds tracked by Wall St. Rank held GE Vernova as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.